| Literature DB >> 28357001 |
Joseph D Everett1, Jeffrey A Rossmann1, David G Kerns1, Ibtisam Al-Hashimi1.
Abstract
The objective of this study was to examine potential benefits of using laser therapy for secular decontamination in conjunction with scaling and root planing in the treatment of chronic periodontitis. The study was performed on 173 teeth in 14 patients in a split-mouth design, one side received scaling and root planing followed by laser therapy using a carbon dioxide (CO2) laser with an ablative handpiece (test group); the contralateral side received scaling and root planing without laser (control group). Clinical and laboratory parameters were evaluated prior to treatment and at 3 and 6 months following therapy; clinical measurements were performed by two blinded examiners. The clinical parameters included measurement of gingival recession (REC), bleeding on probing (BOP), clinical attachment level (CAL), pocket depth (PD), furcation involvement (FUR), and tooth mobility (MOB). Laboratory testing to determine the levels of periodontal pathogens was performed using PCR techniques. The results of the study revealed statistically significant differences in clinical and laboratory parameters at 3 and 6 months after therapy for both test and control groups, but no significant difference was observed between the two groups. However, sites receiving laser therapy tended to show a greater decrease in probing depths, gain in clinical attachment level, and reduced bacterial levels. In conclusion, the overall results of the study suggest a potential benefit of using laser therapy in conjunction with scaling and root planing for the treatment of chronic periodontitis.Entities:
Keywords: Carbon dioxide laser; Laser therapy; Microbial biofilm; PCR analysis; Scaling and root planing
Year: 2017 PMID: 28357001 PMCID: PMC5345326 DOI: 10.2174/1874210601711010079
Source DB: PubMed Journal: Open Dent J ISSN: 1874-2106
Bacterial species detected using asymmetric multiples polymerase chain reaction (PCR).
| Reaction A | Reaction B | Reaction C | Reaction D |
|---|---|---|---|
| Internal Control: Apolipoprotein B |
Clinical parameters for test and control group at baseline, 3 months and 6 months. Mean values are represented for all data and sites with PD≥5mm.
| All Data | PD≥5mm | |||||||
|---|---|---|---|---|---|---|---|---|
| PD (mm) | CAL (mm) | Recession (mm) | BOP (% bleeding) | PI (% Plaque Free) | PD (mm) | CAL (mm) | Recession (mm) | |
| Baseline | ||||||||
| Test | 4.16±0.086 | 4.03±0.084 | -0.13±0.044 | 67.66±4.665 | 22.32±4.300 | 5.74±0.073 | 5.27±0.092 | -0.27±0.052 |
| Control | 3.93±0.083 | 3.72±0.079 | -0.21±0.051 | 70.73±5.458 | 19.84±4.726 | 5.65±0.070 | 5.12±0.070 | -0.35±0.068 |
| Overall | 4.04±0.060 | 3.87±0.058 | -0.17±0.034 | 69.20±4.621 | 21.08±4.197 | 5.70±0.003 | 5.21±0.003 | -0.31±0.002 |
| Baseline to 3 Months | ||||||||
| Test | 0.88±0.076 | 0.77±0.090 | -0.06±0.047 | 27.88±7.054 | -32.54±6.777 | 1.73±0.102 | 1.50±0.118 | -0.12±0.066 |
| Control | 0.71±0.730 | 0.48±0.078 | -0.28±0.052 | 35.52±6.643 | -41.27±4.893 | 1.58±0.106 | 1.21±0.104 | -0.32±0.075 |
| Overall | 0.80±0.053 | 0.63±0.060 | -0.17±0.035 | 31.70±6.453 | -36.90±3.268 | 1.66±0.004 | 1.37±0.004 | -0.22±0.003 |
| 3 Months | ||||||||
| Test | 3.27±0.071 | 3.25±0.077 | -0.07±0.048 | 39.78±5.557 | 54.85±4.617 | 4.01±0.093 | 3.77±0.103 | -0.15±0.068 |
| Control | 3.21±0.074 | 3.23±0.740 | 0.06±0.048 | 35.22±4.599 | 61.11±3.051 | 4.07±0.105 | 3.90±0.105 | -0.03±0.053 |
| Overall | 3.25±0.051 | 3.24±0.053 | 0.00±0.034 | 37.50±4.759 | 57.99±3.268 | 4.04±0.004 | 3.83±0.004 | -0.09±0.002 |
| From 3 Months to 6 Months | ||||||||
| Test | 0.25±0.56 | 0.31±0.074 | 0.05±0.049 | -2.68±4.786 | -4.46±5.258 | 0.28±0.083 | 0.33±0.109 | 0.05±0.072 |
| Control | 0.14±0.055 | 0.17±0.068 | 0.03±0.035 | -2.38±5.520 | -3.27±4.788 | 0.24±0.095 | 0.22±0.107 | 0.03±0.049 |
| Overall | 0.19±0.039 | 0.24±0.050 | 0.04±0.030 | -2.53±4.940 | -3.87±4.333 | 0.26±0.003 | 0.28±0.004 | 0.04±0.002 |
| 6 Months | ||||||||
| Test | 3.02±0.064 | 2.94±0.064 | -0.12±0.049 | 42.46±6.956 | 59.33±5.628 | 3.72±0.079 | 3.44±0.087 | -0.20±0.061 |
| Control | 3.08±0.061 | 3.07±0.066 | 0.03±0.046 | 37.60±5.945 | 64.38±5.396 | 3.83±0.085 | 3.69±0.086 | -0.06±0.058 |
| Overall | 3.05±0.044 | 3.05±0.046 | -0.05±0.034 | 40.03±6.285 | 61.86±4.809 | 3.77±0.003 | 3.56±0.003 | -0.13±0.002 |
| From Baseline to 6 Months | ||||||||
| Test | 1.14±0.073 | 1.08±0.080 | -0.01±0.051 | 25.20±26.363 | -37.00±6.509 | 2.02±0.099 | 1.83±0.107 | -0.07±0.064 |
| Control | 0.85±0.070 | 0.65±0.075 | -0.24±0.049 | 33.13±25.011 | -44.54±6.654 | 1.42±0.101 | 1.44±0.103 | -0.30±0.071 |
| Overall | 0.99±0.051 | 0.87±0.055 | -0.13±0.035 | 29.17±24.178 | -40.77±5.907 | 1.93±0.004 | 1.65±0.004 | -0.18±0.002 |